Bedel Financial Consulting’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $624K | Hold |
14,618
| – | – | 0.06% | 153 |
|
|
2026
Q1 | $917K | Hold |
14,618
| – | – | 0.1% | 112 |
|
|
2025
Q4 | $1.39M | Buy |
14,618
+58
| +0.4% | +$5.69K | 0.15% | 80 |
|
|
2025
Q3 | $1.42M | Buy |
14,560
+1,507
| +12% | +$156K | 0.18% | 78 |
|
|
2025
Q2 | $1.4M | Hold |
13,053
| – | – | 0.19% | 72 |
|
|
2025
Q1 | $1.36M | Hold |
13,053
| – | – | 0.19% | 68 |
|
|
2024
Q4 | $1.37M | Hold |
13,053
| – | – | 0.19% | 72 |
|
|
2024
Q3 | $1.09M | Hold |
13,053
| – | – | 0.15% | 81 |
|
|
2024
Q2 | $1.01M | Hold |
13,053
| – | – | 0.15% | 78 |
|
|
2024
Q1 | $894K | Hold |
13,053
| – | – | 0.14% | 82 |
|
|
2023
Q4 | $755K | Hold |
13,053
| – | – | 0.14% | 92 |
|
|
2023
Q3 | $689K | Hold |
13,053
| – | – | 0.14% | 85 |
|
|
2023
Q2 | $706K | Hold |
13,053
| – | – | 0.15% | 86 |
|
|
2023
Q1 | $653K | Hold |
13,053
| – | – | 0.16% | 87 |
|
|
2022
Q4 | $604K | Hold |
13,053
| – | – | 0.15% | 89 |
|
|
2022
Q3 | $548K | Hold |
13,053
| – | – | 0.15% | 94 |
|
|
2022
Q2 | $486K | Hold |
13,053
| – | – | 0.14% | 104 |
|
|
2022
Q1 | $578K | Sell |
13,053
-47
| -0.4% | -$2.04K | 0.18% | 74 |
|
|
2021
Q4 | $556K | Buy |
13,100
+47
| +0.4% | +$1.98K | 0.17% | 82 |
|
|
2021
Q3 | $566K | Hold |
13,053
| – | – | 0.19% | 77 |
|
|
2021
Q2 | $558K | Buy |
13,053
+794
| +6% | +$33.4K | 0.19% | 78 |
|
|
2021
Q1 | $474K | Hold |
12,259
| – | – | 0.18% | 90 |
|
|
2020
Q4 | $441K | Hold |
12,259
| – | – | 0.2% | 79 |
|
|
2020
Q3 | $468K | Hold |
12,259
| – | – | 0.23% | 61 |
|
|
2020
Q2 | $430K | Hold |
12,259
| – | – | 0.23% | 61 |
|
|
2020
Q1 | $400K | Sell |
12,259
-792
| -6% | -$30.9K | 0.26% | 64 |
|
|
2019
Q4 | $590K | Buy |
13,051
+307
| +2% | +$12.8K | 0.33% | 55 |
|
|
2019
Q3 | $519K | Hold |
12,744
| – | – | 0.31% | 62 |
|
|
2019
Q2 | $548K | Hold |
12,744
| – | – | 0.33% | 56 |
|
|
2019
Q1 | $489K | Hold |
12,744
| – | – | 0.31% | 64 |
|
|
2018
Q4 | $450K | Hold |
12,744
| – | – | 0.32% | 56 |
|
|
2018
Q3 | $485K | Hold |
12,744
| – | – | 0.32% | 62 |
|
|
2018
Q2 | $417K | Hold |
12,744
| – | – | 0.31% | 70 |
|
|
2018
Q1 | $348K | Hold |
12,744
| – | – | 0.26% | 79 |
|
|
2017
Q4 | $316K | Buy |
+12,744
| New | +$351K | 0.28% | 82 |
|
Other funds holding BSX
Bedel Financial Consulting's BSX Position: Q2 2026 in Review
Bedel Financial Consulting held its Boston Scientific (BSX) position steady in Q2 2026 at 14,618 shares worth $624K. The position accounts for 0.06% of the portfolio, ranked #153.
Bedel Financial Consulting first reported a position in BSX in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.42M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Bedel Financial Consulting held 14,618 shares of Boston Scientific worth $624K as of Q2 2026.
- Bedel Financial Consulting left its Boston Scientific share count unchanged in Q2 2026.
- Boston Scientific made up 0.06% of Bedel Financial Consulting's portfolio in Q2 2026, its #153 holding.
- Bedel Financial Consulting first reported a position in Boston Scientific in Q4 2017 and has held it in 35 quarters since.
- Bedel Financial Consulting's Boston Scientific position peaked at $1.42M in Q3 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Bedel Financial Consulting's 13F filing for Q2 2026, filed 29 Jul 2026.